Cargando…
Mucopolysaccharidosis-Plus Syndrome, a Rapidly Progressive Disease: Favorable Impact of a Very Prolonged Steroid Treatment on the Clinical Course in a Child
Mucopolysaccharidosis-plus syndrome (MPS-PS) is a novel autosomal recessive disorder caused by a mutation in the VPS33A gene. This syndrome presents with typical symptoms of mucopolysaccharidosis, as well as congenital heart defects, renal, and hematopoietic system disorders. To date, twenty-four pa...
Autores principales: | Faraguna, Martha Caterina, Musto, Francesca, Crescitelli, Viola, Iascone, Maria, Spaccini, Luigina, Tonduti, Davide, Fedeli, Tiziana, Kullmann, Gaia, Canonico, Francesco, Cattoni, Alessandro, Dell’Acqua, Fabiola, Rizzari, Carmelo, Gasperini, Serena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8951474/ https://www.ncbi.nlm.nih.gov/pubmed/35327996 http://dx.doi.org/10.3390/genes13030442 |
Ejemplares similares
-
Biological therapies in monogenic autoinflammatory diseases: long-term efficacy and safety
por: Pelagatti, Maria A, et al.
Publicado: (2014) -
“Growth patterns in children with mucopolysaccharidosis type I-Hurler after hematopoietic stem cell transplantation: Comparison with untreated patients”
por: Cattoni, Alessandro, et al.
Publicado: (2021) -
FDXR-associated disease: a challenging differential diagnosis with inflammatory peripheral neuropathy
por: Masnada, Silvia, et al.
Publicado: (2023) -
Treatment Dilemma in Children with Late-Onset Pompe Disease
por: Faraguna, Martha Caterina, et al.
Publicado: (2023) -
Proposal of an Algorithm to Early Detect Attenuated Type I Mucopolysaccharidosis (MPS Ia) among Children with Growth Abnormalities
por: Baronio, Federico, et al.
Publicado: (2022)